CareLit · DOI-Nachweis · Pneumologie
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: lung function and safety
DOI 10.1055/s-0034-1368057
Bibliografische Angaben
Nachweis in CareLit
Autor:innenO Schmidt, HAM Kerstjens, E Bleecker, E Meltzer, T Casale, E Pizzichini, M Engel, LJ Bour, CB Verkleij, PM Moroni-Zentgraf, ED Bateman
ZeitschriftPneumologie
Ausgabe02/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Asthma is not controlled in some patients, despite using medium-dose ICS. Methods: Two identical Phase III, randomised, double-blind, double-dummy, placebo (pbo)-controlled, parallel-group trials (NCT01172808/821) assessed tiotropium (tio) efficacy/safety. Patients with symptomatic asthma and pre-bronchodilator FEV1 60 – 90% predicted, using medium-dose ICS (400 – 800 µg budesonide equivalent), were rand…
Zitieren
Zitierempfehlung
O Schmidt, HAM Kerstjens, E Bleecker, E Meltzer, T Casale, E Pizzichini, M Engel, LJ Bour, CB Verkleij, PM Moroni-Zentgraf, ED Bateman (2014) Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: lung function and safety. Pneumologie (02). https://doi.org/10.1055/s-0034-1368057
Mit CareLit weiterarbeiten